These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37881743)

  • 21. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min.
    Nyman U; Almén T; Aspelin P; Hellström M; Kristiansson M; Sterner G
    Acta Radiol; 2005 Dec; 46(8):830-42. PubMed ID: 16392608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
    Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
    Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mehran contrast nephropathy risk score: Is it still useful 10 years later?
    Abellás-Sequeiros RA; Raposeiras-Roubín S; Abu-Assi E; González-Salvado V; Iglesias-Álvarez D; Redondo-Diéguez A; González-Ferreiro R; Ocaranza-Sánchez R; Peña-Gil C; García-Acuña JM; González-Juanatey JR
    J Cardiol; 2016 Mar; 67(3):262-7. PubMed ID: 26169247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-induced nephropathy in urgent coronary interventions.
    Valente S; Lazzeri C; Giglioli C; Margheri M; Comeglio M; Nicolaci L; Chechi T; Gensini GF
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):737-41. PubMed ID: 17001234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].
    He YT; Tan N; Liu YH; Chen SQ; Liu Y; Huang SJ; Yang DH; Ye P; Ran P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):394-8. PubMed ID: 24021122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
    Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
    Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk score for contrast induced nephropathy following percutaneous coronary intervention.
    Ghani AA; Tohamy KY
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):240-5. PubMed ID: 19237811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of low serum hemoglobin on development of contrast-induced nephropathy (CIN) in patients with hepatocellular carcinoma (HCC) following transarterial chemoembolisation (TACE).
    Si Y; Sun W; Zhao K; Liu X; Ren K
    Int Urol Nephrol; 2021 Jun; 53(6):1189-1195. PubMed ID: 33392886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
    Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
    J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
    Nyman U; Björk J; Aspelin P; Marenzi G
    Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inferior vena cava assessment can predict contrast-induced nephropathy in patients undergoing cardiac catheterization: A single-center prospective study.
    Gungoren F; Besli F; Tanriverdi Z; Demirbag R
    Echocardiography; 2018 Dec; 35(12):1915-1921. PubMed ID: 30303247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel risk prediction tool for contrast-induced nephropathy in patients with chronic kidney disease who underwent diagnostic coronary angiography.
    Çetin M; Acehan F; Kundi H; Yakıcı IE; Katipoglu B; Duran G; Yazıcı B; Cetin ZG; Ates I
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3430-3437. PubMed ID: 37140292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography.
    Liu Y; He YT; Tan N; Chen JY; Liu YH; Yang DH; Huang SJ; Ye P; Li HL; Ran P; Duan CY; Chen SQ; Zhou YL; Chen PY
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25888371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast Volume to Cystatin C-Based Glomerular Filtration Ratio Predicts the Risk of Contrast-Induced Nephropathy After Cardiac Catheterization.
    Zhao JB; Liu Y; Wu DX; Chen JY; Duan CY; Chen SQ; Tan N
    Angiology; 2017 Mar; 68(3):207-215. PubMed ID: 27166381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention.
    Gurm HS; Seth M; Kooiman J; Share D
    J Am Coll Cardiol; 2013 Jun; 61(22):2242-8. PubMed ID: 23721921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
    Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
    Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
    Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
    BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F; Yarlioglues M; Cay S; Celik IE; Mendi MA; Kurtul A; Cankurt T; Kuyumcu S; Canpolat U; Turak O
    Am J Cardiol; 2015 Sep; 116(5):711-6. PubMed ID: 26116992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.